重新评估2023年ISCVID Duke感染性心内膜炎诊断标准:排除发热并更新诊断定义的影响
该回顾性研究纳入瑞士两所大学医院2014至2024年3694例疑似感染性心内膜炎(IE)发作,比较2023年ISCVID-Duke标准中包含与排除发热作为次要标准对诊断效能的影响。结果显示排除发热并更新定义后,在“确定IE为阳性”分析中灵敏度从74%升至77%,在“确定或可能IE为阳性”分析中特异度从49%升至80%,结论认为排除发热可显著提高特异度而不损害灵敏度。
要点
- 排除发热作为次要标准并更新定义后,诊断特异度从49%显著提高至80%。
- 排除发热后灵敏度仅从74%小幅升至77%,未见明显损失。
- 发热在IE与非IE发作中 prevalence 相似(78% vs 77%,P=0.484)。
核心结论
- 在2023年ISCVID-Duke框架中排除发热作为次要标准并更新诊断定义,可大幅提高特异度而不降低灵敏度。
- 该发现挑战了发热在IE诊断中的传统作用,支持对长期使用的诊断标准进行更广泛重新评估。
研究设计与样本
- 回顾性研究,纳入瑞士两所大学医院2014至2024年疑似IE发作共3694例。
- 参考标准为心内膜炎团队或专家临床医生的最终诊断。
- 每例发作分别用包含发热与排除发热的两个版本2023 ISCVID-Duke标准进行分类。
- 诊断效能采用两种二分法评估:确定IE为阳性对比可能或排除为阴性;确定或可能IE为阳性对比排除为阴性。
主要发现
- 3694例发作中诊断IE 1331例(36%)。
- 发热见于78%的发作,IE与非IE发作中患病率相似(78% versus 77%;P=0.484)。
- 第一种评估中,灵敏度从原标准的74%(95% CI: 71-76%)升至排除发热并更新定义后的77%(74-79%)。
- 第二种评估中,特异度从49%(47-51%)升至80%(78-82%)。
关键数值与推荐
- 排除发热作为次要标准并更新确定、可能和排除IE的定义后,第一种评估灵敏度77%(74-79%),第二种评估特异度80%(78-82%)。
- 原标准下第一种评估灵敏度74%(95% CI: 71-76%),第二种评估特异度49%(47-51%)。
临床怎么用
- 在疑似IE评估中,可考虑不将发热作为次要诊断标准,以提高诊断特异度。
- 应用更新后的2023 ISCVID-Duke标准时,需注意排除发热对减少假阳性的潜在价值。
局限性
- 本研究为回顾性设计,可能存在选择偏倚和信息偏倚。
- 研究仅纳入瑞士两所大学医院,结果外推性需谨慎。
- 原文未报告发热排除对临床决策或患者结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fever has traditionally been included as a minor criterion in the Duke criteria for the diagnosing infective endocarditis (IE). We evaluated the diagnostic impact of excluding fever as a minor criterion within the 2023 Duke-ISCVID (International Society for Cardiovascular Infectious Diseases) framework. METHODS: : We conducted a retrospective study of suspected IE at two Swiss University Hospitals (2014-2024). The reference standard was the final diagnosis by the Endocarditis Team or expert clinicians. Each episode was classified using two versions of the 2023 ISCVID-Duke criteria: one including and one excluding fever as a minor criterion with updated definitions for definite, possible, and rejected IE. Diagnostic performance was assessed using two dichotomizations: in the first analysis, definite IE was considered positive, and possible or rejected was negative; in the second, definite or possible IE was positive, and rejected was negative. RESULTS: IE was diagnosed in 1331/3694 (36%) episodes. Fever was present in 78% of episodes, with similar prevalence in IE and non-IE episodes (78% versus 77%; P=0.484). Using the first evaluation, sensitivity increased modestly from 74% (95% CI: 71-76%) with the original criteria to 77% (74-79%) after excluding fever and updating definitions. Using the second evaluation, specificity markedly improved from 49% (47-51%) to 80% (78-82%) with these modifications. CONCLUSIONS: Exclusion of fever as a minor criterion within the updated Duke-ISCVID framework substantially improved specificity without compromising sensitivity. These findings challenge the traditional role of fever in IE diagnosis and support a broader re-evaluation of longstanding diagnostic criteria.
引用
- Stavropoulou E, Epprecht J, Siedentop B, et al. Reassessing the 2023 International Society for Cardiovascular Infectious Diseases Duke clinical criteria for infective endocarditis: Impact of excluding fever and updating diagnostic definitions. Clin Infect Dis. 2025. PMID: 41474532. doi:10.1093/cid/ciaf737
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。